The global respiratory therapeutic devices market is expected to grow at a CAGR of 4.5% during the forecast period, from 2021 to 2030. The market is driven by factors such as increasing prevalence of respiratory diseases and growing awareness about the benefits of respiratory therapeutic devices. Nebulizers are one of the most commonly used respiratory therapeutic devices in hospitals and clinics for treating asthma, COPD, cystic fibrosis, and other lung diseases. The nebulizer market is expected to grow at a CAGR of 5% during the forecast period due to increasing prevalence of chronic lung diseases such as asthma and COPD across various regions globally. Humidifiers are also widely used in hospitals and clinics for treating dry coughs or bronchitis caused by cold or flu viruses. The humidifier market is expected to grow at a CAGR of 3% during the forecast period due to rising demand for humidifiers in developing countries such as India and China where air pollution levels are high.
- The global respiratory therapeutic devices market is expected to grow at a CAGR of 4.5% from 2017 to 2022.
- The increasing prevalence of chronic respiratory diseases such as asthma and COPD is one of the major factors driving the growth of this market.
- Increasing awareness about the benefits of using respiratory therapeutic devices for treatment purposes will also drive this market's growth in the coming years.
- Technological advancements in these products are also expected to fuel their demand over the forecast period, as they offer better treatment options for patients with chronic respiratory diseases such as asthma and COPD .
Industry Growth Insights published a new data on “Respiratory Therapeutic Devices Market”. The research report is titled “Respiratory Therapeutic Devices Market research by Types (Nebulizers, Humidifiers), By Applications (Asthma, COPD, Cystic Fibrosis), By Players/Companies Masimo. (U.S.), BD. (U.S.), Smiths Group Plc. (U.S.), F. Hoffmann-La Roche Ltd (Europe), Bayer AG (Europe), Rotech Healthcare Inc. (U.S.), Chart Industries (U.S.), ACare Technology (Asia Pacific)”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Respiratory Therapeutic Devices Market Research Report
By Type
Nebulizers, Humidifiers
By Application
Asthma, COPD, Cystic Fibrosis
By Companies
Masimo. (U.S.), BD. (U.S.), Smiths Group Plc. (U.S.), F. Hoffmann-La Roche Ltd (Europe), Bayer AG (Europe), Rotech Healthcare Inc. (U.S.), Chart Industries (U.S.), ACare Technology (Asia Pacific)
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
250
Number of Tables & Figures
175
Customization Available
Yes, the report can be customized as per your need.
Global Respiratory Therapeutic Devices Market Report Segments:
The global Respiratory Therapeutic Devices market is segmented on the basis of:
Types
Nebulizers, Humidifiers
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Asthma, COPD, Cystic Fibrosis
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Masimo. (U.S.)
- BD. (U.S.)
- Smiths Group Plc. (U.S.)
- F. Hoffmann-La Roche Ltd (Europe)
- Bayer AG (Europe)
- Rotech Healthcare Inc. (U.S.)
- Chart Industries (U.S.)
- ACare Technology (Asia Pacific)
Highlights of The Respiratory Therapeutic Devices Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Nebulizers
- Humidifiers
- By Application:
- Asthma
- COPD
- Cystic Fibrosis
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Respiratory Therapeutic Devices Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Respiratory therapeutic devices (RTDs) are medical devices that are used to help people with respiratory problems breathe better. RTDs can be used in a variety of ways, including as an aid to breathing during sleep, for treating chronic obstructive pulmonary disease (COPD), and for other purposes.
Some of the key players operating in the respiratory therapeutic devices market are Masimo. (U.S.), BD. (U.S.), Smiths Group Plc. (U.S.), F. Hoffmann-La Roche Ltd (Europe), Bayer AG (Europe), Rotech Healthcare Inc. (U.S.), Chart Industries (U.S.), ACare Technology (Asia Pacific).
The respiratory therapeutic devices market is expected to grow at a compound annual growth rate of 4.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Respiratory Therapeutic Devices Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Respiratory Therapeutic Devices Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Respiratory Therapeutic Devices Market - Supply Chain
4.5. Global Respiratory Therapeutic Devices Market Forecast
4.5.1. Respiratory Therapeutic Devices Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Respiratory Therapeutic Devices Market Size (000 Units) and Y-o-Y Growth
4.5.3. Respiratory Therapeutic Devices Market Absolute $ Opportunity
5. Global Respiratory Therapeutic Devices Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Respiratory Therapeutic Devices Market Size and Volume Forecast by Type
5.3.1. Nebulizers
5.3.2. Humidifiers
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Respiratory Therapeutic Devices Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Respiratory Therapeutic Devices Market Size and Volume Forecast by Application
6.3.1. Asthma
6.3.2. COPD
6.3.3. Cystic Fibrosis
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Respiratory Therapeutic Devices Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Respiratory Therapeutic Devices Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Respiratory Therapeutic Devices Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Respiratory Therapeutic Devices Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Respiratory Therapeutic Devices Demand Share Forecast, 2019-2026
9. North America Respiratory Therapeutic Devices Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Respiratory Therapeutic Devices Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Respiratory Therapeutic Devices Market Size and Volume Forecast by Application
9.4.1. Asthma
9.4.2. COPD
9.4.3. Cystic Fibrosis
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Respiratory Therapeutic Devices Market Size and Volume Forecast by Type
9.7.1. Nebulizers
9.7.2. Humidifiers
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Respiratory Therapeutic Devices Demand Share Forecast, 2019-2026
10. Latin America Respiratory Therapeutic Devices Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Respiratory Therapeutic Devices Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Respiratory Therapeutic Devices Market Size and Volume Forecast by Application
10.4.1. Asthma
10.4.2. COPD
10.4.3. Cystic Fibrosis
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Respiratory Therapeutic Devices Market Size and Volume Forecast by Type
10.7.1. Nebulizers
10.7.2. Humidifiers
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Respiratory Therapeutic Devices Demand Share Forecast, 2019-2026
11. Europe Respiratory Therapeutic Devices Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Respiratory Therapeutic Devices Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Respiratory Therapeutic Devices Market Size and Volume Forecast by Application
11.4.1. Asthma
11.4.2. COPD
11.4.3. Cystic Fibrosis
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Respiratory Therapeutic Devices Market Size and Volume Forecast by Type
11.7.1. Nebulizers
11.7.2. Humidifiers
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y GrowthProjections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Respiratory Therapeutic Devices Demand Share, 2019-2026
12. Asia Pacific Respiratory Therapeutic Devices Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Respiratory Therapeutic Devices Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Respiratory Therapeutic Devices Market Size and Volume Forecast by Application
12.4.1. Asthma
12.4.2. COPD
12.4.3. Cystic Fibrosis
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Respiratory Therapeutic Devices Market Size and Volume Forecast by Type
12.7.1. Nebulizers
12.7.2. Humidifiers
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Respiratory Therapeutic Devices Demand Share, 2019-2026
13. Middle East & Africa Respiratory Therapeutic Devices Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Respiratory Therapeutic Devices Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Respiratory Therapeutic Devices Market Size and Volume Forecast by Application
13.4.1. Asthma
13.4.2. COPD
13.4.3. Cystic Fibrosis
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Respiratory Therapeutic Devices Market Size and Volume Forecast by Type
13.7.1. Nebulizers
13.7.2. Humidifiers
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Respiratory Therapeutic Devices Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Respiratory Therapeutic Devices Market: Market Share Analysis
14.2. Respiratory Therapeutic Devices Distributors and Customers
14.3. Respiratory Therapeutic Devices Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Masimo. (U.S.)
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. BD. (U.S.)
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Smiths Group Plc. (U.S.)
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. F. Hoffmann-La Roche Ltd (Europe)
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Bayer AG (Europe)
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Rotech Healthcare Inc. (U.S.)
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Chart Industries (U.S.)
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. ACare Technology (Asia Pacific)
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook